SPG vs VIR · rev $3.55B vs rev $238.9M
SPG (SPG) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
SPG currently screens at market cap $0. VIR currently screens at market cap $1.45B.
Not investment advice. Open the SPG and VIR stock pages for the full models.
Not investment advice.